======= TAOK3 ======= == Gene Information == * **Official Symbol**: TAOK3 * **Official Name**: TAO kinase 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51347|51347]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H2K8|Q9H2K8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAOK3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAOK3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616711|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a serine/threonine protein kinase that activates the p38/MAPK14 stress-activated MAPK cascade but inhibits the basal activity of the MAPK8/JNK cascade. The encoded protein is a member of the GCK subfamily of STE20-like kinases. [provided by RefSeq, Oct 2016]. * **UniProt Summary**: Serine/threonine-protein kinase that acts as a regulator of the p38/MAPK14 stress-activated MAPK cascade and of the MAPK8/JNK cascade. Acts as an activator of the p38/MAPK14 stress- activated MAPK cascade. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. Inhibits basal activity of MAPK8/JNK cascade and diminishes its activation in response epidermal growth factor (EGF). {ECO:0000269|PubMed:10559204, ECO:0000269|PubMed:10924369, ECO:0000269|PubMed:17396146}. |Pkinase Tyr| |Pkinase| |mitotic G2 DNA damage checkpoint| |MAP kinase kinase kinase activity| |mitotic G2/M transition checkpoint| |protein kinase inhibitor activity| |G2 DNA damage checkpoint| |negative regulation of JNK cascade| |negative regulation of stress-activated MAPK cascade| |negative regulation of stress-activated protein kinase signaling cascade| |activation of MAPKK activity| |transferase activity| |positive regulation of JUN kinase activity| |regulation of JUN kinase activity| |negative regulation of G2/M transition of mitotic cell cycle| |mitotic DNA damage checkpoint| |negative regulation of cell cycle G2/M phase transition| |mitotic DNA integrity checkpoint| |DNA damage checkpoint| |positive regulation of JNK cascade| |stress-activated protein kinase signaling cascade| |DNA integrity checkpoint| |mitotic cell cycle checkpoint| |negative regulation of MAPK cascade| |positive regulation of stress-activated MAPK cascade| |positive regulation of stress-activated protein kinase signaling cascade| |regulation of JNK cascade| |cell cycle checkpoint| |protein autophosphorylation| |regulation of G2/M transition of mitotic cell cycle| |regulation of cell cycle G2/M phase transition| |negative regulation of mitotic cell cycle phase transition| |negative regulation of protein kinase activity| |negative regulation of cell cycle phase transition| |regulation of stress-activated MAPK cascade| |regulation of stress-activated protein kinase signaling cascade| |negative regulation of kinase activity| |positive regulation of MAP kinase activity| |negative regulation of transferase activity| |negative regulation of mitotic cell cycle| |negative regulation of cell cycle process| |activation of protein kinase activity| |positive regulation of protein serine/threonine kinase activity| |regulation of MAP kinase activity| |protein serine/threonine kinase activity| |MAPK cascade| |signal transduction by protein phosphorylation| |negative regulation of protein phosphorylation| |regulation of mitotic cell cycle phase transition| |negative regulation of phosphorylation| |regulation of cell cycle phase transition| |negative regulation of intracellular signal transduction| |DNA repair| |regulation of protein serine/threonine kinase activity| |positive regulation of protein kinase activity| |positive regulation of MAPK cascade| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of cell cycle| |positive regulation of kinase activity| |negative regulation of protein modification process| |mitotic cell cycle process| |regulation of mitotic cell cycle| |positive regulation of transferase activity| |mitotic cell cycle| |regulation of cellular response to stress| |DNA metabolic process| |regulation of cell cycle process| |regulation of MAPK cascade| |cellular response to DNA damage stimulus| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of kinase activity| |protein phosphorylation| |regulation of transferase activity| |cell cycle process| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |negative regulation of cellular protein metabolic process| |positive regulation of phosphorylation| |negative regulation of protein metabolic process| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |negative regulation of molecular function| |regulation of cell cycle| |positive regulation of protein modification process| |negative regulation of signal transduction| |phosphorylation| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of response to stress| |ATP binding| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |positive regulation of signal transduction| |intracellular signal transduction| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-2.27| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.22| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.98| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.89| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.74| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|1.75| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15415 * **Expression level (log2 read counts)**: 6.51 {{:chemogenomics:nalm6 dist.png?nolink |}}